[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a
Zika Virus DNA Vaccine in Healthy Adults and Adolescents

What is the purpose of the study?

The main purpose of this study is to see if the experimental vaccine is safe and if there are any side effects. We also want to study immune responses to the vaccine including cells that may recognize and fight Zika virus. This study will take place in areas where Zika outbreaks are happening or may happen.

Upstate Institutional Review Board (IRB) Number:

1077914

Study/Protocol ID:

VRC 705

Study Phase:

Phase III

Patient Age Group:

Adults and Children

Principal Investigator:

Joseph B Domachowske

Who can I contact for more information?

Name: Kelly Bartlett, BA
Phone: 315-464-8235
Email: bartletk@upstate.edu

Return to Previous Page || Search Again

Top